PMV Pharmaceuticals Inc — Balance Sheet (NASDAQ:PMVP) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Total assets 365.53 M331.57 M270.31 M252.15 M191.29 M Total liabilities 6.41 M23.01 M24.28 M26.46 M15.21 M Total equity 359.12 M308.56 M246.03 M225.69 M176.08 M Total liabilities & shareholders' equities 365.53 M331.57 M270.31 M252.15 M191.29 M Total debt ————— Net debt —————

Новости

Исследование резатапопта от PMV Pharma опубликовано в NEJM

PMV Pharma’s rezatapopt study published in New England Journal

OrbiMed Advisors продает акции PMV Pharma на $1,52 млн

OrbiMed Advisors sells PMV Pharma (PMVP) shares for $1.52 million

PMV Pharmaceuticals, Inc. (PMVP) Presents at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Slideshow (NASDAQ:PMVP) 2025-10-25

Акции PMV Pharmaceuticals растут на фоне успешных испытаний препарата

PMV Pharmaceuticals stock rises on positive cancer drug trial data

PMV Pharma представит первичные данные по терапии мутации TP53 на онкологической конференции

PMV Pharma to present initial data on TP53 mutation therapy at cancer conference

Акции PMV Pharmaceuticals сохраняют рейтинг "Покупать" от H.C. Wainwright на основе данных испытаний

PMV Pharmaceuticals stock holds Buy rating at H.C. Wainwright on trial data

PMV Pharmaceuticals, Inc. (PMVP) Special Call - Slideshow (NASDAQ:PMVP)